Marilynn Vetzel

1.5k total citations
28 papers, 1.3k citations indexed

About

Marilynn Vetzel is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Marilynn Vetzel has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Marilynn Vetzel's work include Folate and B Vitamins Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Marilynn Vetzel is often cited by papers focused on Folate and B Vitamins Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Marilynn Vetzel collaborates with scholars based in United States. Marilynn Vetzel's co-authors include Christopher P. Leamon, Joseph A. Reddy, Iontcho R. Vlahov, Elaine Westrick, Le-Cun Xu, Nikki Parker, Ryan Dorton, Paul J. Kleindl, Jeffrey S. Nicoson and Matthew Parker and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Marilynn Vetzel

28 papers receiving 1.2k citations

Peers

Marilynn Vetzel
Paul J. Kleindl United States
Hari Krishna R. Santhapuram United States
Takanori Kawaguchi Japan
Kenneth D. Bagshawe United Kingdom
Robert S. Greenfield United States
Marianne Budde Netherlands
Manuela Porru Italy
Le-Cun Xu United States
Masaki Nogawa Japan
Nader Hanna United States
Paul J. Kleindl United States
Marilynn Vetzel
Citations per year, relative to Marilynn Vetzel Marilynn Vetzel (= 1×) peers Paul J. Kleindl

Countries citing papers authored by Marilynn Vetzel

Since Specialization
Citations

This map shows the geographic impact of Marilynn Vetzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilynn Vetzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilynn Vetzel more than expected).

Fields of papers citing papers by Marilynn Vetzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilynn Vetzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilynn Vetzel. The network helps show where Marilynn Vetzel may publish in the future.

Co-authorship network of co-authors of Marilynn Vetzel

This figure shows the co-authorship network connecting the top 25 collaborators of Marilynn Vetzel. A scholar is included among the top collaborators of Marilynn Vetzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilynn Vetzel. Marilynn Vetzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reddy, Joseph A., Melissa Nelson, Marilynn Vetzel, et al.. (2020). Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent. Scientific Reports. 10(1). 12772–12772. 8 indexed citations
2.
Lu, Yingjuan, Haiyan Chu, Leroy W. Wheeler, et al.. (2019). Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies. Frontiers in Oncology. 9. 151–151. 46 indexed citations
3.
Leamon, Christopher P., Joseph A. Reddy, Ryan Dorton, et al.. (2019). Prostate-Specific Membrane Antigen-Specific Antitumor Activity of a Self-Immolative Tubulysin Conjugate. Bioconjugate Chemistry. 30(6). 1805–1813. 27 indexed citations
4.
Reddy, Joseph A., Ryan Dorton, Melissa Nelson, et al.. (2018). Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic. Scientific Reports. 8(1). 8943–8943. 33 indexed citations
5.
Lu, Yingjuan, Haiyan Chu, Leroy W. Wheeler, et al.. (2018). Abstract LB-109: Adaptor controlled CAR-T cell immunotherapy for treatment of folate receptor-alpha/beta positive solid and liquid tumors. Cancer Research. 78(13_Supplement). LB–109. 2 indexed citations
6.
Leamon, Christopher P., Joseph A. Reddy, Iontcho R. Vlahov, et al.. (2017). Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy. Cancer Chemotherapy and Pharmacology. 79(6). 1151–1160. 10 indexed citations
7.
Guertin, Amy D., Jennifer O’Neil, Alexander Stoeck, et al.. (2016). High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide. Molecular Cancer Therapeutics. 15(8). 1998–2008. 16 indexed citations
8.
Leamon, Christopher P., Iontcho R. Vlahov, Joseph A. Reddy, et al.. (2014). Folate–Vinca Alkaloid Conjugates for Cancer Therapy: A Structure–Activity Relationship. Bioconjugate Chemistry. 25(3). 560–568. 54 indexed citations
9.
Reddy, Joseph A., et al.. (2014). Abstract 832: Pre-clinical development of EC1456: A potent Folate targeted Tubulysin SMDC. Cancer Research. 74(19_Supplement). 832–832. 7 indexed citations
10.
Leamon, Christopher P., Joseph A. Reddy, Ryan Dorton, et al.. (2012). Abstract 3622: Predicting response to EC145 therapy using the folate receptor-specific radiodiagnostic imaging agent, 99mTc-EC20. Cancer Research. 72(8_Supplement). 3622–3622. 2 indexed citations
11.
Vlahov, Iontcho R., Yu Wang, Marilynn Vetzel, et al.. (2011). Acid mediated formation of an N-acyliminium ion from tubulysins: A new methodology for the synthesis of natural tubulysins and their analogs. Bioorganic & Medicinal Chemistry Letters. 21(22). 6778–6781. 16 indexed citations
12.
Leamon, Christopher P., Joseph A. Reddy, Patrick Klein, et al.. (2010). Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications. Journal of Pharmacology and Experimental Therapeutics. 336(2). 336–343. 41 indexed citations
13.
Reddy, Joseph A., Ryan Dorton, Marilynn Vetzel, et al.. (2009). In Vivo Structural Activity and Optimization Studies of Folate−Tubulysin Conjugates. Molecular Pharmaceutics. 6(5). 1518–1525. 54 indexed citations
14.
Leamon, Christopher P., Joseph A. Reddy, Marilynn Vetzel, et al.. (2008). Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue. Cancer Research. 68(23). 9839–9844. 81 indexed citations
15.
Leamon, Christopher P., Joseph A. Reddy, Iontcho R. Vlahov, et al.. (2007). Comparative preclinical activity of the folate‐targeted Vinca alkaloid conjugates EC140 and EC145. International Journal of Cancer. 121(7). 1585–1592. 70 indexed citations
16.
Reddy, Joseph A., Elaine Westrick, Hari Krishna R. Santhapuram, et al.. (2007). Folate Receptor–Specific Antitumor Activity of EC131, a Folate-Maytansinoid Conjugate. Cancer Research. 67(13). 6376–6382. 67 indexed citations
17.
Leamon, Christopher P., Joseph A. Reddy, Iontcho R. Vlahov, et al.. (2007). Preclinical Antitumor Activity of a Novel Folate-Targeted Dual Drug Conjugate. Molecular Pharmaceutics. 4(5). 659–667. 89 indexed citations
18.
Reddy, Joseph A., Hari Krishna R. Santhapuram, Elaine Westrick, et al.. (2006). Folate receptor targeted anti-tumor activity of EC-0225, a folate-targeted dual drug conjugate. Cancer Research. 66. 135–135. 1 indexed citations
19.
Lu, Yingjuan, Nikki Parker, Elaine Westrick, et al.. (2006). Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate–targeted immunotherapy in hapten-immunized mice. Molecular Cancer Therapeutics. 5(12). 3258–3267. 32 indexed citations
20.
Leamon, Christopher P., Matthew Parker, Iontcho R. Vlahov, et al.. (2002). Synthesis and Biological Evaluation of EC20:  A New Folate-Derived, 99mTc-Based Radiopharmaceutical. Bioconjugate Chemistry. 13(6). 1200–1210. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul J. Kleindl Breakdown of academic impact, for papers by Hari Krishna R. Santhapuram Breakdown of academic impact, for papers by Takanori Kawaguchi Breakdown of academic impact, for papers by Kenneth D. Bagshawe Breakdown of academic impact, for papers by Robert S. Greenfield Breakdown of academic impact, for papers by Marianne Budde Breakdown of academic impact, for papers by Manuela Porru Breakdown of academic impact, for papers by Le-Cun Xu Breakdown of academic impact, for papers by Masaki Nogawa Breakdown of academic impact, for papers by Nader Hanna
Rankless by CCL
2026